Hemostasis Diagnostics Market by Product Type (Laboratory Systems, Consumables, and Point-of-Care Testing Systems), by Test Type (Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen Degradation Products (FDP), Activated Clotting Time, Platelet Aggregation Test, and D Dimer), and by End-User (Hospital & Clinics, Independent Diagnostic Laboratories, and Home Care Settings)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2017—2024

                                          
Abstract
                    
The report covers a forecast and an analysis of the Hemostasis Diagnostics Market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints of the Hemostasis Diagnostics Market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Hemostasis Diagnostics Market on a global level.

In order to give the users of this report a comprehensive view of the Hemostasis Diagnostics Market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved on the market on a global and regional basis.

The study provides a decisive view of the hemostasis diagnostics market by segmenting the market based on product type, test type, end-user, and region. All the segments have been analyzed based on present and future trends and the market are estimated from 2018 to 2024. 

By product type, the hemostasis diagnostics market is segmented into laboratory systems, consumables, and point-of-care testing systems. By test type, the hemostasis diagnostics market is segmented into prothrombin test time (PT), activated partial thromboplastin time (APTT), fibrinogen degradation products (FDP), activated clotting time, platelet aggregation test, and D dimer. By end-user, the hemostasis diagnostics Market is segmented into hospital and clinics, independent diagnostic laboratories, and home care settings.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries, such as the U.S., Germany, France, UK, China, Japan, India, and Brazil.

The major players of the global hemostasis diagnostics market include Siemens Healthineers, Abbott Laboratories, Instrumentation Laboratory, Thermo Fisher Scientific Inc., Alere Inc., Nihon Kohden Corporation, Sysmex Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Grifols S.A. 

This report segments the global hemostasis diagnostics market into:

Global Hemostasis Diagnostics Market: Product Type Analysis

	Laboratory Systems
	Consumables
	Point-of-Care Testing Systems

Global Hemostasis Diagnostics Market: Test Type Analysis

	Prothrombin Test Time (PT)
	Activated Partial Thromboplastin Time (APTT)
	Fibrinogen Degradation Products (FDP)
	Activated Clotting Time
	Platelet Aggregation Test
	D Dimer

Global Hemostasis Diagnostics Market: End-User Analysis

	Hospital and Clinics
	Independent Diagnostic Laboratories
	Home Care Settings

Global Hemostasis Diagnostics Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa